Ceribell is a neurotechnology company focused on improving acute neurological care through rapid EEG acquisition and automated analysis. The company develops portable EEG hardware paired with cloud-connected software designed for use in emergency and critical care environments.

Ceribell’s system combines an easy-to-apply EEG headband with machine-learning algorithms that analyze brain activity in real time to identify seizure patterns. The platform is designed to reduce time to diagnosis, support non-specialist clinicians, and address gaps in continuous EEG availability in hospitals.

Ceribell’s technology is deployed in emergency departments, intensive care units, and acute care settings to support faster diagnosis and treatment decisions for patients with suspected seizures. The company positions its solution as a diagnostic infrastructure layer that augments clinical workflows rather than a traditional neuroimaging modality.